PIWIL2 and neoplasm: Our molecular and functional studies, demonstrated Piwil2 as a key player in the process of tumor initiation, progression and invasion, suggestthat this factor can be used as a common cancerbiomarker, as well as a target for the developmentof new anticancer drug.